Shinkin Capital Founded -
Founders
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$51M
Portfolio companies 8
Rounds per year -
Lead investments -
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits -
Key employees -
Areas of investment
Artificial Intelligence
Biopharma
Biotechnology
Health Diagnostics
Robotics
Software
Summary

The fund was located in Asia if to be more exact in Japan. The main office of represented VC is situated in the Tokyo.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Linkwiz, REGiMMUNE Corporation. Among the most popular fund investment industries, there are Biopharma, Robotics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Shinkin Capital, startups are often financed by Japan Asia Investment, Yasuda Enterprise Development, SMBC Venture Capital. The meaningful sponsors for the fund in investment in the same round are SMBC Venture Capital, Hamashin Lease, Shizuoka Capital Wealth Management. In the next rounds fund is usually obtained by Venture Labo Investment Co.,Ltd, SMBC Venture Capital, Toppan Forms.

The top activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 1 - 5 millions dollars.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
ANSeen
Real Estate
Series B
137M07 Sep 2020 Japan, Shizuoka
REGiMMUNE Corporation
Biopharma
Biotechnology
Health Diagnostics
Series C
5M01 Feb 2012 Japan, Chiyoda
ANSeen
Real Estate
Series A
45M21 Nov 2018 Japan, Shizuoka
AI Samurai
Artificial Intelligence
Information Technology
Product Research
Series B
53M30 Oct 2018 Japan, Chiyoda
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Shinkin Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: